6月11日中欧医疗创新股票A净值下跌1.50%，近1个月累计上涨17.63%

Group 1 - The core point of the news is the performance and holdings of the China Europe Medical Innovation Stock A fund, which has shown significant returns over various time frames [1] - As of June 11, 2025, the latest net value of the fund is 1.4281 yuan, reflecting a decrease of 1.50% [1] - The fund's one-month return is 17.63%, ranking 14 out of 447 in its category; the six-month return is 27.45%, ranking 15 out of 441; and the year-to-date return is 37.34%, ranking 16 out of 444 [1] Group 2 - The top ten stock holdings of the fund account for a total of 75.62%, with the largest positions being WuXi AppTec (10.35%), Kelun-Biotech (10.15%), WuXi Biologics (9.82%), and WuXi PharmaTech (9.60%) [1] - The fund was established on February 28, 2019, and as of March 31, 2025, it has a total scale of 4.675 billion yuan [1] - The fund manager is Ms. Ge Lan, who has extensive experience in the investment management field [2]